Remove Aortic valve Remove Heart Disease Remove Tricuspid
article thumbnail

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected.

Tricuspid 105
article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111
article thumbnail

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

Heart BMJ

Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD).

article thumbnail

Characteristics and prognosis of isolated aortic valve infective endocarditis in patients with bicuspid aortic valves: a propensity matched study

Frontiers in Cardiovascular Medicine

Introduction Bicuspid aortic valve (BAV) is the most common congenital heart disease with an increased risk of infective endocarditis (IE). The aim of this study was to compare patients with tricuspid aortic valve (TAV) IE and BAV-IE in terms of characteristics, management and prognosis.

article thumbnail

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

DAIC

We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. This milestone makes AISAP the first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heart diseases using POCUS.

article thumbnail

Study: Robotic Arm Can be Used for Remote Echocardiograms

DAIC

Echocardiograms using the robotic arm resulted in the same diagnosis as conventional in-person echocardiography in 98% of cases (papillary muscle level obstruction was missed in one case).

article thumbnail

Basics of Echocardiography

All About Cardiovascular System and Disorders

A good knowledge of the anatomy of the heart is needed for interpretation of images from each view. This becomes more difficult in complex congenital heart diseases where the cardiac chamber positions and size may vary. This view images the heart from the base to apex long axis view.